Author

Karin Linderfalk

Lund UniversityORCID 0009-0009-1331-4483Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Agatheeswaran SubramaniamiD· 1 shared Alejandro Garcia GarciaiD· 1 shared Bai Yiguang· 1 shared David HidalgoiD· 1 shared Deepak Bushan RainaiD· 1 shared Dimitra ZacharakiiD· 1 shared Ludvig Nilsén Falck· 1 shared Paul Emile BourgineiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Agatheeswaran SubramaniamORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivJul 28, 2023

Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines

Sujeethkumar Prithiviraj, Alejandro Garcia Garcia, Karin Linderfalk…·Paul Emile Bourgine

This study uses CRISPR/Cas9 to edit human mesenchymal stem cells to produce engineered extracellular matrices with modified VEGF and RUNX2 expression, showing altered osteogenic properties.

9 citations

humangenetic perturbation / CRISPR

𝕏 PostBluesky